D4 Diagnostics has developed D4BST to quantify the number of immune cells in tumors prior to treatment. D4BST is an assay for accurate, fast and reliable quantification of B-, Switched B- and T cells in traces of DNA from tumors or its surrounding environment.

DEPREDICT uses cutting-edge machine learning and neuroimaging MRI to address the urgent need for decision support in treating depression, a global health crisis impacting over 40 million Europeans annually.

Assisting people to make diet-related lifestyle changes through gaming

A new class of dual drugs for cancer treatment which are well tolerated and can be taken orally

EdgeLeap is an information technology company pushing AI to its limits to surface business relevant insights from continuous stream of world’s information, helping their clients can make intelligent strategic decisions every day.

Firbornectin-EDA Monoclonal antibody for the prevention of chronic heart failure

Encytos has developed a micro(nano)structured (topographic) inorganic substrate for spheroid and organoid cell growth.

Simple blood tests to detect cancer

Opposed to the current heparin production method, our technology has the potential to ensure supply security, reduce risk of contamination and remove dependency on animal material.

We created a method of projecting a surgical planning onto the patient. This way the surgeon spends less time on preparation (20 min) and performs surgeries faster (19 min). The prototype is in continuous use in Radboudumc (400+ surgeries).